Ginisortamab
Product Specifications
UNSPSC Description
Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ginisortamab.html
Purity
99.05
Solubility
10 mM in DMSO
Smiles
[Ginisortamab]
References & Citations
[1]Debashis Sarker, et al. A multi-modular phase I/II study of UCB6114, a first-in-class, fully human IgG4P anti-Gremlin-1 monoclonal antibody, as monotherapy and in combination with mFOLFOX6 or trifluridine/tipiracil, for patients with advanced gastrointestinal (GI) tumors. Meeting Abstract, 2022 ASCO Gastrointestinal Cancers Symposium.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99643/Ginisortamab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99643/Ginisortamab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2390147-17-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BNUB2718-500 500 µL
Anti-PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus)(PAPPA/2718)
Ask
View Details